American Bio Medica Corporation (ABMC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -768 Thousand | -673 Thousand | -483 Thousand | 58 Thousand | -220 Thousand | 181 Thousand |
| Net Income | -1.41 Million | -463 Thousand | -796 Thousand | -681 Thousand | -1.02 Million | -545 Thousand |
| Depreciation & Amortization | 51 Thousand | 68 Thousand | 79 Thousand | 81 Thousand | 81 Thousand | 80 Thousand |
| Deferred income taxes | -15 Thousand | - | 160 Thousand | 94 Thousand | 118 Thousand | 54 Thousand |
| Stock-based compensation | 15 Thousand | - | 2000.00 | 6000.00 | 10 Thousand | 43 Thousand |
| Change in working capital | 620 Thousand | -181 Thousand | -17 Thousand | 433 Thousand | 467 Thousand | 423 Thousand |
| Other non-cash items | -29 Thousand | -97 Thousand | 89 Thousand | 125 Thousand | 132 Thousand | 126 Thousand |
| Investing Cash Flow | - | - | -4000.00 | - | -22 Thousand | -64 Thousand |
| Investments in PPE | - | - | -4000.00 | - | -22 Thousand | -64 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -22.00 | -20.00 |
| Financing Cash Flow | 687 Thousand | 690 Thousand | 581 Thousand | -167 Thousand | 319 Thousand | -237 Thousand |
| Debt repayment | -1.16 Million | -2.24 Million | -4.05 Million | -4.08 Million | -4.16 Million | -6.02 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 100 Thousand | 199 Thousand | - | 200 Thousand | - |
| Other Financing Activities | 1.85 Million | 2.83 Million | 4.43 Million | 3.92 Million | 4.27 Million | 5.78 Million |
| Accounts receivables | 242 Thousand | 103 Thousand | -40 Thousand | 84 Thousand | -88 Thousand | 205 Thousand |
| Accounts payables | 78 Thousand | 105 Thousand | -75 Thousand | 293 Thousand | -15 Thousand | 70 Thousand |
| Inventory | 107 Thousand | 92 Thousand | 117 Thousand | 113 Thousand | 320 Thousand | 58 Thousand |
| Other working capital | 193 Thousand | -481 Thousand | -19 Thousand | -57 Thousand | 250 Thousand | 90 Thousand |
| Cash at beginning of period | 115 Thousand | 98 Thousand | 4000.00 | 113 Thousand | 36 Thousand | 156 Thousand |
| Cash at end of period | 34 Thousand | 115 Thousand | 98 Thousand | 4000.00 | 113 Thousand | 36 Thousand |
| Capital Expenditure | - | - | -4000.00 | - | -22 Thousand | -64 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -81 Thousand | 17 Thousand | 94 Thousand | -109 Thousand | 77 Thousand | -120 Thousand |
| Free Cash Flow | -768 Thousand | -673 Thousand | -487 Thousand | 58 Thousand | -242 Thousand | 117 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | 1.88 Million | -1.41 Million | -317 Thousand | -314 Thousand |
| Depreciation & Amortization | - | - | 8000.00 | 51 Thousand | 13 Thousand | 12 Thousand |
| Deferred income taxes | - | - | - | -15 Thousand | - | - |
| Stock-based compensation | - | - | - | 15 Thousand | - | - |
| Change in working capital | - | - | -138 Thousand | 620 Thousand | -286 Thousand | 231 Thousand |
| Other non-cash items | - | - | -2.11 Million | -29 Thousand | -21 Thousand | -4000.00 |
| Investing Cash Flow | - | - | 247 Thousand | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 247 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 247.00 | - | - | - |
| Financing Cash Flow | - | - | 150 Thousand | 687 Thousand | 635 Thousand | 83 Thousand |
| Debt repayment | - | - | -100 Thousand | -1.16 Million | -40 Thousand | -275 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 250 Thousand | 1.85 Million | 675 Thousand | 358 Thousand |
| Accounts receivables | - | - | -7000.00 | 242 Thousand | -43 Thousand | 45 Thousand |
| Accounts payables | - | - | 24 Thousand | 78 Thousand | -190 Thousand | 65 Thousand |
| Inventory | - | - | - | 107 Thousand | 22 Thousand | 25 Thousand |
| Other working capital | - | - | -17 Thousand | 193 Thousand | -75 Thousand | 96 Thousand |
| Cash at beginning of period | - | 68 Thousand | 34 Thousand | 115 Thousand | 10 Thousand | 2000.00 |
| Cash at end of period | - | 68 Thousand | 68 Thousand | 34 Thousand | 34 Thousand | 10 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 34 Thousand | -81 Thousand | 24 Thousand | 8000.00 |
| Free Cash Flow | - | - | -363 Thousand | -768 Thousand | -611 Thousand | -75 Thousand |
CGNX
002574
0J9O
MOH
KPHWF
SREEJAYA